InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Bornstein Jeffrey S, Director. Director active across 1 company, notably Allovir, Inc.. In total, 3 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €99k. History available since 10 February 2022. The latest transaction was filed on 26 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
5,000 shares@ US$4.639321.9% of flowCommon StockSEC:0000899243-22-015826:0
Ideal exit: 21 Jan 2023 (T+270)
5,000 shares@ US$8.8739.0% of flowCommon StockSEC:0000899243-22-005623:0
Ideal exit: 7 Nov 2022 (T+270)
5,000 shares@ US$8.87100.0% of flowCommon StockSEC:0000899243-22-005623
Ideal exit: 7 Nov 2022 (T+270)
3 of 3 declarations
About Bornstein Jeffrey S
Jeffrey S. Bornstein is a Director at Allovir, Inc. He contributes to the governance and oversight of the company's activities, bringing his expertise in the biopharmaceutical sector. His role is essential in guiding strategic decisions.
